Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits
PLOS Biology · 2024
DOI: 10.1371/journal.pbio.3002537 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2024. Verfasst von Jiao Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and the Research Units of West China, Chinese…. Hauptthemen laut MEDLINE: Lipopolysaccharides, Proteomics. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Defective autophagy is linked to proinflammatory diseases. However, the mechanisms by which autophagy limits inflammation remain elusive. Here, we found that the pan-FGFR inhibitor LY2874455 efficiently activated autophagy and suppressed expression of proinflammatory factors in macrophages stimulated by lipopolysaccharide (LPS). Multiplex proteomic profiling identified the immunoproteasome, which is a specific isoform of the 20s constitutive proteasome, as a substrate that is degraded by selective autophagy. SQSTM1/p62 was found to be a selective autophagy-related receptor that mediated this degradation. Autophagy deficiency or p62 knockdown blocked the effects of LY2874455, leading to the accumulation of immunoproteasomes and increases in inflammatory reactions. Expression of proinflammatory factors in autophagy-deficient macrophages could be reversed by immunoproteasome inhibitors, confirming the pivotal role of immunoproteasome turnover in the autophagy-mediated suppression on the expression of proinflammatory factors. In mice, LY2874455 protected against LPS-induced acute lung injury and dextran sulfate sodium (DSS)-induced colitis and caused low levels of proinflammatory cytokines and immunoproteasomes. These findings suggested that selective autophagy of the immunoproteasome was a key regulator of signaling via the innate immune system.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and the Research Units of West China, Chinese Academy of Medical Sciences, Chengdu, China.
- National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, China.
- Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen People's Hospital, Shenzhen…
- West China Second University Hospital, Sichuan University, Chengdu, China.
Förderung
- National Key R&D Program of China
- National Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zhou, J., Li, C., Lu, M., Jiang, G., Chen, S., Li, H., & Lu, K. (2024). Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002537
Vancouver
Zhou J, Li C, Lu M, Jiang G, Chen S, Li H, et al. Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits. PLOS Biology. 2024. doi:10.1371/journal.pbio.3002537
BibTeX
@article{Zhou2024,
author = {Zhou, Jiao and Li, Chunxia and Lu, Meng and Jiang, Gaoyue and Chen, Shanze and Li, Huihui and Lu, Kefeng},
title = {Pharmacological induction of autophagy reduces inflammation in macrophages by degrading immunoproteasome subunits},
journal = {PLOS Biology},
year = {2024},
doi = {10.1371/journal.pbio.3002537}
}
EUVIMED